*One enrolled participant was later found to not meet eligibility criteria and was subsequently discontinued from product use, one enrolled participant was erroneously thought to not meet eligibility
Additional file 5. Supplementary Tables 1-12. (S1) Inclusion reason in the high-risk cohort, (S2) Cohort characteristics in breast cancer, healthy volunteers and high-risk cohorts, (S3) Discomfort of
AbstractIntroduction:Mycophenolate mofetil (MMF), pro-drug mycophenolic acid (MPA) is an immunosuppressive effective in the prophylaxis of acute rejection, but associated with gastrointestinal advers
Daily Morphine Study Description To reduce pain, anxiety, or agitation, critically ill children routinely receive opioids for analgesia and sedation. Routine use of opioid therapy often leads to toler
